Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid infusion versus bolus in cyanotic congenital heart surgery
ACTRN12617001176358Phase 4Completed
- Sponsor
- Irfan Akhter
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in Cardiovascular Malformation (CVM) (2 arms), sponsored by Irfan Akhter. Primary endpoints: Post-operative bleeding and Chest closure time. Started Jul 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ACTRN12617001176358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001176358.